Cardiometabolic Health Congress (CMHC)
Avatar

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
8,246 views
June 17, 2019
3 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

08:46
Robert Busch

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

26:49
Diana Isaacs

Tirzepatide Updates

19:23
PKD Foundation

Genetic Testing in PKD: The Benefits and the Challenges

Feat. L. Noureddine
20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

38:09
Houston Methodist Hospital

Multimodal Integrative Approach to Kidney Disease: Dietary Managemen…

Feat. K. Kalantar-Zadeh
05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

23:35
Canadian Collaborative Research Network

Is Obesity Management the Next Frontier?

Feat. A. Michael Lincoff
14:15
Insights From The World Congress of Nephrology 2024

Some Highlights of the 2024 KDIGO CKD Guidelines

Feat. K. Zuber